Cargando…
LBSAT59 Overnight Metyrapone Test And Urine Steroid Profiling In Patients Treated With Chronic Opioid Therapy: Prevalence Of Adrenal Insufficiency
BACKGROUND: Patients taking chronic opioids are at high risk of opioid induced adrenal insufficiency (OIAI). Previously, we showed that the prevalence of OIAI was 9% based on low morning cortisol, corticotropin (ACTH), and dehydroepiandrosterone sulfate (DHEAS). Data on the overnight metyrapone test...
Autores principales: | Saini, Jasmine, Gilliam, Wesley P, Cunningham, Julie L, Thangamuthu, Karthik, Gruber, Lucinda M, Singh, Sumitabh, Sutor, Bruce, Michael Hooten, W, Bancos, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626924/ http://dx.doi.org/10.1210/jendso/bvac150.094 |
Ejemplares similares
-
SAT300 Use of Overnight Metyrapone Test In Suspected Adrenal Insufficiency: A Retrospective Single Center-Study
por: Saini, Jasmine, et al.
Publicado: (2023) -
LBSAT56 Adrenal And Juxta-adrenal Schwannomas: A Single Center Study
por: Rolak, Stacey, et al.
Publicado: (2022) -
SAT-383 Prevalence of Opioid Induced Adrenal Insufficiency in Patients Taking Chronic Opioids
por: Li, Taoran, et al.
Publicado: (2019) -
ODP650 Impaired Cognition in Patients with Mild Autonomous Cortisol Secretion
por: Nathani, Rohit, et al.
Publicado: (2022) -
Adrenal Cushing’s in Pregnancy, Managed with Metyrapone to Optimize for Adrenalectomy at 27 Weeks Gestation
por: Shah, Leena, et al.
Publicado: (2021)